共 75 条
Cardiovascular Therapies and Associated Glucose Homeostasis Implications Across the Dysglycemia Continuum
被引:38
作者:
Cooper-DeHoff, Rhonda M.
[1
]
Pacanowski, Michael A.
[2
,3
]
Pepine, Carl J.
[1
]
机构:
[1] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL 32610 USA
[2] Univ Florida, Dept Pharm Practice, Gainesville, FL 32610 USA
[3] Univ Florida, Ctr Pharmacogenom, Coll Pharm, Gainesville, FL 32610 USA
关键词:
IMPAIRED FASTING GLUCOSE;
LIPID-LOWERING TREATMENT;
ANGIOTENSIN RECEPTOR BLOCKERS;
HEALED MYOCARDIAL-INFARCTION;
TYPE-2;
DIABETES-MELLITUS;
CORONARY-ARTERY-DISEASE;
METABOLIC SYNDROME;
INSULIN-RESISTANCE;
CLINICAL-OUTCOMES;
ANTIHYPERTENSIVE TREATMENT;
D O I:
10.1016/j.jacc.2008.10.037
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Certain cardiovascular drugs have adverse effects on glucose homeostasis, which may lead to important long-term implications for increased risks of adverse outcomes. Thiazide diuretics, niacin, and beta-adrenergic blockers impair glucose homeostasis. However, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers have demonstrated beneficial metabolic effects. The newer vasodilating beta-blocking agents and calcium antagonists appear to be metabolically neutral. These considerations, in addition to meticulous attention to blood pressure control and lifestyle changes, have the potential to beneficially modify glycemia and long-term risks. These considerations have particular importance in younger patients who may also have pre-diabetes or the metabolic syndrome and who are likely to require therapy over the course of decades. (J Am Coll Cardiol 2009;53:S28-34) (C) 2009 by the American College of Cardiology Foundation
引用
收藏
页码:S28 / S34
页数:7
相关论文